Octapharma AB Octapharma Pharmaceuticals Production GmbH Octapharma SAS
PolandAll drugs from this manufacturer
-
The medicine is used for the treatment and prevention of bleeding in patients with hemophilia A, which results from a deficiency of coagulation factor VIII in the blood.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor viii 100 j.m./ml ATC: B02BD02
-
Pharmavate is used for the treatment and prevention of bleeding in patients with hemophilia A, which results from a deficiency of coagulation factor VIII in the blood.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor viii 50 j.m./ml ATC: B02BD02